HOME | CONTACT | BLOG | SITE MAP   

Press Releases

VetStem Biopharma is pleased to announce that Dr Scott Gustafson will be presenting our preliminary data for Canine Allogeneic Mesenchymal stem cells at ACVS

VetStem Biopharma is pleased to announce that Dr Scott Gustafson will be presenting our preliminary data for Dose Confirmation Study of Intraarticular Allogeneic Adipose Stem Cells for the Treatment of Osteoarthritis in Dogs at the American College of Vet

August 22, 2016 --

Scott Gustafson, DVM, DACVS will be presenting VetStem Biopharma’s preliminary data from the completion of a field clinical study of its’ canine osteoarthritis stem cell product, currently under formal development for FDA approval. The product is being co-developed with Aratana Therapeutics (Kansas City, MO) and will be marketed in the US by Aratana.  This product, termed AT-016, is an allogeneic adipose stem cell product for the treatment of osteoarthritis in the dog.  The formal FDA Investigational New Drug Application was filed in 2011. Dr Gustafson will be presenting Canine Allogeneic Mesenchymal Stem Cells Osteoarthritis a Prospective Trial on Thursday October 6th at 2:15pm during the Regenerative Medicine in Orthopedics session.  

Dr Gustafson received his DVM from Oregon State University and Washington State University in 1985. He received his MS in Veterinary Surgery from Colorado State University in 1989 and became a Diplomat of the American College of Veterinary Surgeons in 1990. Dr Gustafson performs orthopedic, soft tissue, arthroscopy, laparoscopy, thoracoscopy and cancer surgeries. Dr. Gustafson played a major role in developing the small animal teaching hospital and small animal surgical curriculum at OSU, and taught small animal surgery at Oregon State University College of Veterinary Medicine. He has utilized VetStem autologous Stem Cell clinical applications since 2006 and has treated over 60 animal patients. He has lectured nationally on Stem Cell Therapy and was one of the investigational study veterinarians that participated in this phase of the study. Dr Gustafson is the current owner of Surgery4Pets in Willamette Valley, Oregon.

The American College of Veterinary Surgeons Summit will be held in Seattle, WA, from October 6th through the 8th.  The Summit will feature over 325 lectures covering the latest clinical and research information in the surgical and medical fields. Internationally recognized specialists will discuss their clinical experience as well as evidence-based scientific advances. The summit will also offer 15 laboratory sessions, including Canine Sports Medicine, Wound Management, and Minimally Invasive Surgery Training for Technicians.

VetStem CEO said “We are excited to share our investigational study. This is the first of its kind in the canine stem cell field and builds upon more than a decade of commitment to an evidenced-based approach to delivering regenerative medicine to our profession. Dr Gustafson has been one of the pioneers in incorporating regenerative medicine into his surgical practice.”





< Back to Press Releases     

 


  • Success Stories
    News
    Videos
    Blog
    Press Releases
    Facebook
    Twitter
     


      COMPANY
    Management
    Investors
    Contact Us
    Careers
    Privacy Policy
    SCIENCE
    FAQs
    Literature Refs
    Safety
    PET & HORSE OWNERS
    Dogs & Cats
    Horses
    Locate a Vet
    FAQs
    VETERINARIANS
    Vet Login /
    Credentialing

    Dogs & Cats
    Horses
    FAQs
    MEDIA ROOM
    Press Releases
    Success Stories
    News
    Videos
    Blog
    LOCATE A VET

    CONTACT US
     

    COPYRIGHT 2011 VETSTEM BIOPHARMA. ALL RIGHTS RESERVED.
    12860 Danielson Court, Suite B, Poway, CA 92064 Phone: 858-748-2004 or 888-387-8361